Ignite Creation Date:
2025-12-25 @ 12:40 AM
Ignite Modification Date:
2026-05-11 @ 4:59 PM
Study NCT ID:
NCT01322867
Status:
COMPLETED
Last Update Posted:
2021-01-28
First Post:
2011-03-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Bioequivalence Study Of A New Alprazolam Dropped Formulation Versus Alprazolam Tablets
Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
A6131023
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None